$TEVA Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$TEVA SEC Filings

Filing Filed On
2 PR': GLYBURIDE+ALENDRONATE 31 Jan 2005
TEVA ANNOUNCES GLOBAL IN-MARKET FOURTH QUARTER SALES OF COPAXONE? INCREASED 26% 26 Jan 2005
TEVA ANNOUNCES APPROVAL OF FLUCONAZOLE INJECTION 18 Jan 2005
TEVA ANNOUNCES THAT AZILECT? (RASAGILINE) IS APPROVED FOR MARKETING IN ISRAEL 04 Jan 2005
TEVA BOARD OF DIRECTORS INCREASES REPURCHASE PROGRAM TO UP TO $600 MILLION OF TE 21 Dec 2004
TEVA ANNOUNCES TENTATIVE APPROVAL OF ROSIGLITAZONE MALEATE TABLETS 21 Dec 2004
TEVA LAUNCHES QUINAPRIL HCL TABLETS; PURSUANT TO AGREEMENT WITH RANBAXY 16 Dec 2004
TEVA ANNOUNCES APPROVAL AND LAUNCH OF GABAPENTIN TABLETS 15 Dec 2004
TEVA ANNOUNCES TENTATIVE APPROVAL OF METFORMIN HCL EXTENDED RELEASE TABLETS, 750 14 Dec 2004
TEVA ANNOUNCES TENTATIVE APPROVAL OF OXYCODONE HYDROCHLORIDE ER TABLETS, 10 MG, 13 Dec 2004
TEVA CLOSES ACQUISITION OF PFIZER'S ITALIAN GENERIC PHARMACEUTICAL OPERATION - D 01 Dec 2004
TEVA ANNOUNCES PROMOTIONS AND ADDITIONS TO ITS MANAGEMENT TEAM 30 Nov 2004
TEVA ANNOUNCES APPROVAL OF CILOSTAZOL TABLETS 29 Nov 2004
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 23 Nov 2004
TEVA ANNOUNCES TENTATIVE APPROVAL OF FOSPHENYTOIN SODIUM INJECTION 22 Nov 2004
TEVA AND LUNDBECK ANNOUNCE THAT AZILECT? (RASAGILINE) FOR PARKINSON'S DISEASE IS 18 Nov 2004
FORM 6-K 05 Nov 2004
TEVA TO BROADCAST THIRD QUARTER 2004 EARNINGS LUNCHEON ON THE WEB 04 Nov 2004
TEVA REPORTS RECORD Q3 SALES, NET INCOME, EPS AND CASH FLOW 04 Nov 2004
TEVA ANNOUNCES TENTATIVE APPROVAL OF FINASTERIDE TABLETS USP, 5 MG 27 Oct 2004